Randomized Study of Patients (Patient Choice) Who Are Not Eligible for Variations of Standard of Care Protocols When Treated Either on Best Standard of Care Pathways or Per a Protocol Arm That They Failed to Enroll to
All patients failing to enroll in a specific therapeutic research protocol using FDA
approved drugs or CTMS accepted therapies will be screened for this study. Patients will be
randomized (Patient own choice) to either standard of care described in the NCCN guidelines
and published as peer-reviewed phase II or III studies which show an efficacy or to one of
the arms of the protocol they fail to enroll in, as determined by the treating physician.
Interventional
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Number of courses delivered (relative dose intensity for adjuvant studies)
6 months
No
Claire Verschraegen, MD
Principal Investigator
University of New Mexico Cancer Center
United States: Institutional Review Board
INST 0813
NCT01010334
March 2009
July 2011
Name | Location |
---|---|
University of New Mexico | Albuquerque, New Mexico 87131 |